Along with gastrointestinal side effects arising from changes in appetite and diet, some patients also experience headaches and fatigue
However, its broader regulatory status is complex - FDA has raised regulatory and safety concerns regarding certain BPC-157-related bulk substances used in compounding contexts, and classifications may vary by use, jurisdiction, and product category
Diabetes Care 2022;45:659665 [DOI] [PMC free article] [PubMed] [Google Scholar] 208
Both medications reduce appetite through different pathways, and their combined effect might lead to inadequate caloric and nutrient intake, potentially causing muscle loss, vitamin deficiencies, or metabolic complications
doi: 10.1139/Y10-001
It distributes into tissues and persists in myo-inositol pools for weeks